Report cover image

Global Primaquine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 16, 2075
Length 76 Pages
SKU # APRC20263546

Description

Summary

According to APO Research, The global Primaquine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Primaquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Primaquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Primaquine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Primaquine include Cyper Pharma, Santa Cruz Biotechnology, Summit Medical Group and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Primaquine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Primaquine.

The Primaquine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Primaquine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Primaquine Segment by Company

Cyper Pharma
Santa Cruz Biotechnology
Summit Medical Group
Pfizer
Primaquine Segment by Type

Injectables Primaquine
Tablets Primaquine
Capsules Primaquine
Primaquine Segment by Application

Laboratory
Hospital
Clinic
Others
Primaquine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primaquine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Primaquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

76 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Primaquine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Primaquine Sales Estimates and Forecasts (2020-2031)
1.3 Primaquine Market by Type
1.3.1 Injectables Primaquine
1.3.2 Tablets Primaquine
1.3.3 Capsules Primaquine
1.4 Global Primaquine Market Size by Type
1.4.1 Global Primaquine Market Size Overview by Type (2020-2031)
1.4.2 Global Primaquine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Primaquine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Primaquine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Primaquine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Primaquine Sales Breakdown by Type (2020-2025)
1.5.4 South America Primaquine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Primaquine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Primaquine Industry Trends
2.2 Primaquine Industry Drivers
2.3 Primaquine Industry Opportunities and Challenges
2.4 Primaquine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Primaquine Revenue (2020-2025)
3.2 Global Top Players by Primaquine Sales (2020-2025)
3.3 Global Top Players by Primaquine Price (2020-2025)
3.4 Global Primaquine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Primaquine Major Company Production Sites & Headquarters
3.6 Global Primaquine Company, Product Type & Application
3.7 Global Primaquine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Primaquine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Primaquine Players Market Share by Revenue in 2024
3.8.3 2023 Primaquine Tier 1, Tier 2, and Tier 3
4 Primaquine Regional Status and Outlook
4.1 Global Primaquine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Primaquine Historic Market Size by Region
4.2.1 Global Primaquine Sales in Volume by Region (2020-2025)
4.2.2 Global Primaquine Sales in Value by Region (2020-2025)
4.2.3 Global Primaquine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Primaquine Forecasted Market Size by Region
4.3.1 Global Primaquine Sales in Volume by Region (2026-2031)
4.3.2 Global Primaquine Sales in Value by Region (2026-2031)
4.3.3 Global Primaquine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Primaquine by Application
5.1 Primaquine Market by Application
5.1.1 Laboratory
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 Global Primaquine Market Size by Application
5.2.1 Global Primaquine Market Size Overview by Application (2020-2031)
5.2.2 Global Primaquine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Primaquine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Primaquine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Primaquine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Primaquine Sales Breakdown by Application (2020-2025)
5.3.4 South America Primaquine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Primaquine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Cyper Pharma
6.1.1 Cyper Pharma Comapny Information
6.1.2 Cyper Pharma Business Overview
6.1.3 Cyper Pharma Primaquine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cyper Pharma Primaquine Product Portfolio
6.1.5 Cyper Pharma Recent Developments
6.2 Santa Cruz Biotechnology
6.2.1 Santa Cruz Biotechnology Comapny Information
6.2.2 Santa Cruz Biotechnology Business Overview
6.2.3 Santa Cruz Biotechnology Primaquine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Santa Cruz Biotechnology Primaquine Product Portfolio
6.2.5 Santa Cruz Biotechnology Recent Developments
6.3 Summit Medical Group
6.3.1 Summit Medical Group Comapny Information
6.3.2 Summit Medical Group Business Overview
6.3.3 Summit Medical Group Primaquine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Summit Medical Group Primaquine Product Portfolio
6.3.5 Summit Medical Group Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Primaquine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Primaquine Product Portfolio
6.4.5 Pfizer Recent Developments
7 North America by Country
7.1 North America Primaquine Sales by Country
7.1.1 North America Primaquine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Primaquine Sales by Country (2020-2025)
7.1.3 North America Primaquine Sales Forecast by Country (2026-2031)
7.2 North America Primaquine Market Size by Country
7.2.1 North America Primaquine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Primaquine Market Size by Country (2020-2025)
7.2.3 North America Primaquine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Primaquine Sales by Country
8.1.1 Europe Primaquine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Primaquine Sales by Country (2020-2025)
8.1.3 Europe Primaquine Sales Forecast by Country (2026-2031)
8.2 Europe Primaquine Market Size by Country
8.2.1 Europe Primaquine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Primaquine Market Size by Country (2020-2025)
8.2.3 Europe Primaquine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Primaquine Sales by Country
9.1.1 Asia-Pacific Primaquine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Primaquine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Primaquine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Primaquine Market Size by Country
9.2.1 Asia-Pacific Primaquine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Primaquine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Primaquine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Primaquine Sales by Country
10.1.1 South America Primaquine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Primaquine Sales by Country (2020-2025)
10.1.3 South America Primaquine Sales Forecast by Country (2026-2031)
10.2 South America Primaquine Market Size by Country
10.2.1 South America Primaquine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Primaquine Market Size by Country (2020-2025)
10.2.3 South America Primaquine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Primaquine Sales by Country
11.1.1 Middle East and Africa Primaquine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Primaquine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Primaquine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Primaquine Market Size by Country
11.2.1 Middle East and Africa Primaquine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Primaquine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Primaquine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Primaquine Value Chain Analysis
12.1.1 Primaquine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Primaquine Production Mode & Process
12.2 Primaquine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Primaquine Distributors
12.2.3 Primaquine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.